Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2013; 24(16): 2073-2076
DOI: 10.1055/s-0033-1339518
DOI: 10.1055/s-0033-1339518
letter
A Formal Synthesis of (±)-Tylophorine Based on an Atom Transfer Radical Addition Reaction
Further Information
Publication History
Received: 31 May 2013
Accepted after revision: 14 July 2013
Publication Date:
21 August 2013 (online)
![](https://www.thieme-connect.de/media/synlett/201316/lookinside/thumbnails/10.1055-s-0033-1339518-1.jpg)
Abstract
A short, formal synthesis of (±)-tylophorine was achieved using a radical–ionic sequence for the preparation of epoxides as the key step. This sequence, carried out between a phenantrenic allylic alcohol and iodoacetonitrile, provided an advanced intermediate containing most of the required elements for the final construction of the indolizidine scaffold.
Supporting Information
- for this article is available online at http://www.thieme-connect.com/ejournals/toc/synlett.
- Supporting Information
-
References and Notes
- 1a Ratnagiriswaran AN, Venkatachalam K. Indian J. Med. Res. 1935; 22: 433
- 1b Chopra RN, Chakerburty M. Indian J. Med. Res. 1935; 23: 263
- 2 Yang C.-W, Chuang T.-H, Wu P.-L, Huang W.-H, Lee S.-J. Biochem. Biophys. Res. Commun. 2007; 354: 942
- 3a Ganguly T, Sainis KB. Phytomedicine 2001; 8: 348
- 3b Niphakis MJ, Gay BC, Hong KH, Bleeker NP, Georg GI. Bioorg. Med. Chem. 2012; 20: 5893
- 3c Gao W, Bussom S, Grill SP, Gullen EA, Hu Y.-C, Huang X, Zhong S, Kaczmarek C, Gutierrez J, Francis S, Baker DC, Yu S, Cheng Y.-C. Bioorg. Med. Chem. Lett. 2007; 17: 4338
- 3d Wei L, Shi Q, Bastow KF, Brossi A, Morris-Natschke SL, Nakagawa-Goto K, Wu T.-S, Pan Shiow-Lin P, Lee K.-H. J. Med. Chem. 2007; 50: 3674
- 3e Gao W, Chen AP.-C, Leung C.-H, Gullen EA, Fürstner A, Shi Q, Wei L, Lee K.-H, Cheng Y.-C. Bioorg. Med. Chem. Lett. 2008; 18: 704
- 4a Staerk D, Christensen J, Lemmich E, Duus JO, Olsen CE, Jaroszewski JW. J. Nat. Prod. 2000; 63: 1584
- 4b Gao W, Lam W, Zhong S, Kacszmarek C, Baker DC, Cheng Y.-C. Cancer Res. 2004; 64: 678
- 4c Zeng W, Chemler SR. J. Org. Chem. 2008; 73: 6045
- 5 Stoye A, Peez TE, Opatz T. J. Nat. Prod. 2013; 76: 275
- 6 Buckley TF, Rapoport H. J. Org. Chem. 1983; 48: 4222
- 7 Ilida H, Watanabe Y, Tanaka M, Kibayashi C. J. Org. Chem. 1984; 49: 2412
- 8 Commins DL, Chen X, Morgan LA. J. Org. Chem. 1997; 62: 7435
- 9 Lahm G, Stoye A, Opatz T. J. Org. Chem. 2012; 77: 6620
- 10 Fürster A, Kennedy JW. J. Chem. Eur. J. 2006; 12: 7398
- 11a Rossiter LM, Slater ML, Giessert RE, Sakwa SA, Herr RJ. J. Org. Chem. 2009; 74: 9554
- 11b Mai DN, Wolfe JP. J. Am. Chem. Chem. Soc. 2010; 132: 12157
- 12 Hsu S.-F, Ko C.-W, Wu Y.-T. Adv. Synth. Catal. 2011; 353: 1756
- 13 Stoye A, Opatz T. Org. Lett. 2010; 12: 2140
- 14 Peralta-Hernández E, Cortezano-Arellano O, Cordero-Vargas A. Tetrahedron Lett. 2011; 52: 6899
- 15 Weinreb SM, Khatri NA, Shringarpure J. J. Am. Chem. Soc. 1979; 110: 5073
- 16 Caddick S, Judd DB, Lewis AK. K, Reich MT, Williams MR. V. Tetrahedron 2003; 59: 5417
- 17 Synthesis of 11 from 10b To a solution of 10b (0.1 g, 0.2 mmol) on Et3N (0.04 mL, 0.4 mmol) in CH2Cl2 (5 mL) was added dropwise MsCl (0.03 mL, 0.4 mmol). The resulting mixture was stirred for 1 h at r.t. and then H2O was added. The reaction was extracted with CH2Cl2 (3 × 20 mL), the organic phase was dried with Na2SO4, and the solvent removed in vacuo. The product was used without purification for the next reaction. The crude was dissolved in DMF (1 mL) and transferred via cannula to a suspension of NaH (0.008g, 0.34 mmol, of 60% dispersion in mineral oil). The reaction mixture was stirred for 4 h at r.t. Then, H2O was added, and the reaction was extracted with Et2O (3 × 20 mL). The organic phase was dried with Na2SO4, and the solvent was removed in vacuo to yield the colorless solid 11. The product was purified by flash chromatography with hexane–EtOAc (9:1). All spectroscopic data for compound 11 fully matched with those reported by Fürstner.10 H NMR (400 MHz, CDCl3): δ = 1.26 (s, 9 H), 1.60–1.74 (m, 1 H), 1.75–1.90 (m, 2 H), 1.92–2.10 (m, 1 H), 2.55–2.65 (m 1 H), 3.27–3.37 (m, 1 H), 3.45–3.52 (m, 1 H), 3.90–3.97 (m, 1 H), 4.03 (s, 3 H), 4.11 (s, 3 H), 4.12 (s, 3 H), 4.21 (s, 3 H), 4.23–4.32 (m, 1 H), 7.17 (s, 1 H), 7.37 (s, 1 H), 7.79 (s, 1 H), 7.82 (br s, 1 H), 8.31 (br s, 1 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 22.7, 28.6, 29.7, 37.1, 46.8, 55.9, 56.0, 56.2, 56.7, 57.4, 79.0, 102.9, 106.8, 107.9, 123.9, 124.7, 125.2, 126.2, 126.3, 131.8, 148.7, 148.9, 149.0, 149.1, 154.7 ppm. MS (EI) m/z (%) = 481 (45) [M+], 311 (78), 170 (20), 114 (100), 70 (58), 57 (40). HRMS–FAB: m/z calcd for C28H35NO6 [M+]: 481.2464; found: 481.2459.